Results 181 to 190 of about 611,323 (305)
Choosing a Route of Administration for Quadrivalent Meningococcal Polysaccharide Vaccine: Intramuscular versus Subcutaneous [PDF]
Frederick L. Ruben+9 more
openalex +1 more source
Patel RR, Liang SY, Koolwal P, Kuhlmann FM. Therapeutics and Clinical Risk Management. 2015;11:217–228.On page 224, Meningococcal vaccine heading, second sentence “Vaccination is recommended with the quadrivalent polysaccharide (Menactra ...
Patel RR+3 more
doaj
Meningococcal C Polysaccharide Vaccine Induces Immunologic Hyporesponsiveness in Adults: Additional Data [PDF]
James E. Froeschle+2 more
openalex +1 more source
Meningococcal Disease among United States Military Service Members in Relation to Routine Uses of Vaccines with Different Serogroup‐Specific Components, 1964–1998 [PDF]
John F. Brundage+3 more
openalex +1 more source
Introduction Invasive meningococcal disease (IMD) is a severe and life-threatening disease. In the United States (US), vaccine coverage with MenACWY and MenB meningococcal vaccines is suboptimal among adolescents/young adults aged 16–23 years. A combined
Shahina Begum+7 more
doaj +1 more source
Safety, Reactogenicity, and Immunogenicity of a Tetravalent Meningococcal Polysaccharide–Diphtheria Toxoid Conjugate Vaccine Given to Healthy Adults [PDF]
James Campbell+5 more
openalex +1 more source
A Glycoconjugate Vaccine forNeisseria meningitidisInduces Antibodies in Human Infants That Afford Protection against Meningococcal Bacteremia in a Neonate Rat Challenge Model [PDF]
Kenneth T. Mountzouros+4 more
openalex +1 more source